Dataciencia

Colección SciELO Chile

Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting

Indexado

WoS	WOS:000486385600019
Scopus	SCOPUS_ID:85066848671

DOI

10.1016/J.GIE.2019.03.024

Año

2019

Tipo

artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Abstract

Conclusions: DMR shows potential as an endoscopic intervention that improves glycemic and hepatic parameters in patients with T2D. Further mechanistic and clinical studies are underway to further explore DMR as a treatment for metabolic disease.

Revista

Revista	ISSN
Gastrointestinal Endoscopy	0016-5107

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Gastroenterology & Hepatology

Scopus
Sin Disciplinas

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Haidry, Rehan	Hombre	Univ Coll Hosp - Reino Unido UCL - Reino Unido University College Hospital - Reino Unido
2	van Baar, Annieke C.	-	Acad Med Ctr - Países Bajos Amsterdam UMC - University of Amsterdam - Países Bajos
3	Galvao-Neto, Manoel Passos	Hombre	FLORIDA INT UNIV - Estados Unidos Endovitta Inst - Brasil Florida International University - Estados Unidos Endovitta Institute - Brasil
4	Rajagopalan, Harith	-	Fractyl Labs Inc - Estados Unidos Fractyl Laboratories, Inc - Estados Unidos Fractyl Laboratories Inc - Estados Unidos
5	Caplan, Jay	-	Fractyl Labs Inc - Estados Unidos Fractyl Laboratories, Inc - Estados Unidos Fractyl Laboratories Inc - Estados Unidos
6	Levin, Philip S.	Hombre	Adv Devices - Estados Unidos Advanced Devices - Estados Unidos
7	Bergman, Jacques J.	Hombre	Acad Med Ctr - Países Bajos Amsterdam UMC - University of Amsterdam - Países Bajos
8	RODRIGUEZ-GRUNERT, LEONARDO ANTONIO	Hombre	Centro Clinico de Obesidad, Diabetes y Reflujo - Chile CCO Clinical Center for Diabetes, Obesity and Reflux - Chile
9	Deviere, Jacques	Hombre	Erasme Univ Hosp - Bélgica Hospital Erasme - Bélgica Hôpital Erasme - Bélgica
10	Thompson, Christopher C.	Hombre	Brigham & Womens Hosp - Estados Unidos Brigham and Women's Hospital - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento

Fuente
Boston Scientific Corporation
Fractyl Laboratories, Inc., Lexington, Mass
Fractyl
Fractyl Laboratories, Inc.
Apollo Endosurgery
C2 Therapeutics
Endotools Therapeutics
Aspire Bariatrics and Spatz FGIA

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
These studies were supported by Fractyl Laboratories, Inc., Lexington, Mass. Medical writing support, funded by Fractyl, was provided by Caroline Walsh Cazares, PhD, of JB Ashtin, who assisted in implementing author revisions throughout the editorial process.
DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: R. J. Haidry: Research support recipient from and consultant for Cook Endoscopy, Pentax Europe, Medtronic, C2 Therapeutics, and Fractyl. M. P. G. Neto: Research support recipient from Fractyl; consultant for Ethicon Endosurgery, Medtronics, GI Windows, GI Dynamics, Apollo Endosugery, and Fractyl. H. Rajagopalan, J. Caplan: Employees and shareholders of Fractyl. P. S. Levin: Consultant and shareholder for Fractyl. J. J. Bergman: Research support recipient from Fractyl. L. Rodriguez: Consultant for Fractyl. J. Deviere: Research grant recipient from Boston Scientific, Cook, Olympus, and Fractyl; consultant for Olympus, Endotools Therapeutics, and Cook. C. C. Thompson: Research grant recipient from Aspire Bariatrics and Spatz FGIA; consultant for GI Windows, Boston Scientific, Medtronic, USGI Medical, Olympus, Apollo Endosurgery, Fractyl, and GI Dynamics. All other authors disclosed no financial relationships relevant to this publication.

Agradecimiento

These studies were supported by Fractyl Laboratories, Inc., Lexington, Mass. Medical writing support, funded by Fractyl, was provided by Caroline Walsh Cazares, PhD, of JB Ashtin, who assisted in implementing author revisions throughout the editorial process.

DISCLOSURE: The following authors disclosed financial relationships relevant to this publication: R. J. Haidry: Research support recipient from and consultant for Cook Endoscopy, Pentax Europe, Medtronic, C2 Therapeutics, and Fractyl. M. P. G. Neto: Research support recipient from Fractyl; consultant for Ethicon Endosurgery, Medtronics, GI Windows, GI Dynamics, Apollo Endosugery, and Fractyl. H. Rajagopalan, J. Caplan: Employees and shareholders of Fractyl. P. S. Levin: Consultant and shareholder for Fractyl. J. J. Bergman: Research support recipient from Fractyl. L. Rodriguez: Consultant for Fractyl. J. Deviere: Research grant recipient from Boston Scientific, Cook, Olympus, and Fractyl; consultant for Olympus, Endotools Therapeutics, and Cook. C. C. Thompson: Research grant recipient from Aspire Bariatrics and Spatz FGIA; consultant for GI Windows, Boston Scientific, Medtronic, USGI Medical, Olympus, Apollo Endosurgery, Fractyl, and GI Dynamics. All other authors disclosed no financial relationships relevant to this publication.